Raghu Rao
CIK 1806689 · Chief Executive Officer · last filed 2025-12-03
Raghu Rao is a Chief Executive Officer who has filed 8 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for SONN, was dated Dec 3, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Chief Executive Officer | 0 | $1.26 | $0 | $0 | 8 | 2025-12-03 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Disp (D) | −22,356 | $0 | EDGAR |
| 2025-07-15 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2024-12-05 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +373 | $0 | EDGAR |
| 2023-10-27 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Buy (P) | +15,625 | $0 | EDGAR |
| 2022-12-22 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +3,770 | $0 | EDGAR |
| 2022-04-08 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +14,152 | $0 | EDGAR |
| 2020-07-02 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +8,005 | $0 | EDGAR |
| 2020-04-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +213 | $0 | EDGAR |